Michael R. Foley - 30 Dec 2021 Form 3 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
Chief Medical Officer
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Issuer symbol
SERA
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
3
Filing time
04 Jan 2022, 15:15:52 UTC
Next filing
31 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SERA Stock Option (right to buy) 30 Dec 2021 Class A Common Stock 9,620 $1.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest over two years as follows: 1/24 of the original grant amount vests in monthly installments for two years following the vesting commencement date, which is May 18, 2020.

Remarks:

EXHIBIT 24.1 - Power of Attorney